All Phenotypes Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Ets2^tm3Rgo/Ets2^tm3.1Rgo Meox2^tm1(cre)Sor/? Tg(MMTV-PyVTY315FY322F)Db-1Mul/?	involves: 129S4/SvJae * C57BL/6 * FVB/N	MGI:3615252
cn2	Ets2^tm3Rgo/Ets2⁺ Meox2^tm1(cre)Sor/? Tg(MMTV-PyVTY315FY322F)Db-1Mul/?	involves: 129S4/SvJae * C57BL/6 * FVB/N	MGI:3615263
tg3	Tg(MMTV-PyVTY315FY322F)Db-1Mul/?	FVB/N-Tg(MMTV-PyVTY315FY322F)Db-1Mul	MGI:3614342

Allelic Composition	Ets2^tm3Rgo/Ets2^tm3.1Rgo Meox2^tm1(cre)Sor/? Tg(MMTV-PyVTY315FY322F)Db-1Mul/?
Genetic Background	involves: 129S4/SvJae * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2^tm3.1Rgo mutation (0 available); any Ets2 mutation (39 available)
Ets2^tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2^tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary gland tumor incidence ( J:102368 )

• delayed onset of mammary tumors with a median onset of 174 days, a significant delay of 37 days from control group

• once tumors appeared, the rate of tumor growth was not detectably altered

endocrine/exocrine glands

increased mammary gland tumor incidence ( J:102368 )

• delayed onset of mammary tumors with a median onset of 174 days, a significant delay of 37 days from control group

• once tumors appeared, the rate of tumor growth was not detectably altered

mammary gland hyperplasia ( J:102368 )

• the epithelial hyperplasia of mutant mice filled less of the mammary fat pad than control

integument

increased mammary gland tumor incidence ( J:102368 )

• delayed onset of mammary tumors with a median onset of 174 days, a significant delay of 37 days from control group

• once tumors appeared, the rate of tumor growth was not detectably altered

mammary gland hyperplasia ( J:102368 )

• the epithelial hyperplasia of mutant mice filled less of the mammary fat pad than control

Allelic Composition	Ets2^tm3Rgo/Ets2⁺ Meox2^tm1(cre)Sor/? Tg(MMTV-PyVTY315FY322F)Db-1Mul/?
Genetic Background	involves: 129S4/SvJae * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2^tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2^tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased mammary gland tumor incidence ( J:102368 )

• onset of mammary tumors with a median onset of 137 days

• this mutant was used as control for Ets2^tm3Rgo/Ets2^tm3.1Rgo Meox2^tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

endocrine/exocrine glands

increased mammary gland tumor incidence ( J:102368 )

• onset of mammary tumors with a median onset of 137 days

• this mutant was used as control for Ets2^tm3Rgo/Ets2^tm3.1Rgo Meox2^tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

integument

increased mammary gland tumor incidence ( J:102368 )

• onset of mammary tumors with a median onset of 137 days

• this mutant was used as control for Ets2^tm3Rgo/Ets2^tm3.1Rgo Meox2^tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

endocrine/exocrine glands

increased mammary adenocarcinoma incidence ( J:56327 )

• female specific phenotype, extensive mammary epithelial hyperplasias eventually developed mammary tumors with 100% penetrance

• compared to transgenic mice expressing wild-type plyomavirus middle T antigen, there was a significant delay in induction of tumors

• the tumors appeared to be less differentiated than tumors expressing wild-type plyomavirus middle T antigen or mutant plyomavirus middle T antigen with Y to F mutation at position 250

mammary gland hyperplasia ( J:56327 )

• female specific phenotype, global induction of extremely cystic and dilated mammary epithelial hyperplasia without defined alveolar structures in 12-week-old virgin animals

• the mammary epithelium were incapable of nursing

increased mammary gland apoptosis ( J:56327 )

• mammary epithelial hyperplasias displayed extensive apoptotic cell death

neoplasm

increased mammary adenocarcinoma incidence ( J:56327 )

• female specific phenotype, extensive mammary epithelial hyperplasias eventually developed mammary tumors with 100% penetrance

• compared to transgenic mice expressing wild-type plyomavirus middle T antigen, there was a significant delay in induction of tumors

• the tumors appeared to be less differentiated than tumors expressing wild-type plyomavirus middle T antigen or mutant plyomavirus middle T antigen with Y to F mutation at position 250

integument

increased mammary adenocarcinoma incidence ( J:56327 )

• female specific phenotype, extensive mammary epithelial hyperplasias eventually developed mammary tumors with 100% penetrance

• compared to transgenic mice expressing wild-type plyomavirus middle T antigen, there was a significant delay in induction of tumors

• the tumors appeared to be less differentiated than tumors expressing wild-type plyomavirus middle T antigen or mutant plyomavirus middle T antigen with Y to F mutation at position 250

mammary gland hyperplasia ( J:56327 )

• female specific phenotype, global induction of extremely cystic and dilated mammary epithelial hyperplasia without defined alveolar structures in 12-week-old virgin animals

• the mammary epithelium were incapable of nursing

increased mammary gland apoptosis ( J:56327 )

• mammary epithelial hyperplasias displayed extensive apoptotic cell death

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
breast cancer		DOID:1612	OMIM:114480	J:56327

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24